(Q36777380)

16 August 2017

1 reference

title

Elevated mazes as animal models of anxiety: effects of serotonergic agents (English)

1 reference

Frederico Guilherme Graeff

16 August 2017

2

Hélio Zangrossi

0 references

4

object named as

Frederico G Graeff

0 references

author name string

Simone H Pinheiro

1

1 reference

16 August 2017

Hélio Zangrossi

2

1 reference

16 August 2017

Cristina M Del-Ben

3

1 reference

16 August 2017

Frederico G Graeff

4

1 reference

16 August 2017

1 March 2007

1 reference

Anais da Academia Brasileira de Ciências

16 August 2017

1 reference

16 August 2017

79

1 reference

16 August 2017

1

1 reference

16 August 2017

71-85

1 reference

Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze

16 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Serotonin, the periaqueductal gray and panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

The elevated T-maze as an experimental model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Does the panic attack activate the hypothalamic-pituitary-adrenal axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Effects of sibutramine on anxiety-related behaviours in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

The conditioned emotional response (CER) as a baseline for the study of anti-anxiety drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

A risk-benefit assessment of buspirone in the treatment of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

5-HT1A receptor knockout mouse as a genetic model of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Animal models for the study of anti-anxiety agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Behavioral validation of the elevated T-maze, a new animal model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

Some quantitative properties of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652007000100010

10.1590/S0001-37652007000100010

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference